The H1-4 knockout HEK293T polyclonal cells are a CRISPR/Cas9-edited polyclonal cell population derived from HEK293T human embryonic kidney cells, carrying targeted disruptions in the H1-4 gene encoding linker histone H1.4. This heterogeneous knockout model enables loss-of-function studies of chromatin biology, gene regulation, and DNA damage responses without clonal selection artifacts, while preserving broad representation of genetic edits.
HEK293T cells are a widely used human cell line expressing SV40 large T antigen, which facilitates high-level protein expression and lentivirus production. With epithelial morphology and rapid growth, HEK293T is a standard platform for transient and stable transfection, signal transduction research, and cancer cell line engineering, making it an ideal host for chromatin-focused knockout studies.
Linker histone H1.4 binds nucleosomes and linker DNA to compact chromatin into higher-order structures, globally repressing gene transcription. It is regulated by E2F transcription factors, NPAT, and Cyclin E/CDK2, and is phosphorylated by ATM and ATR upon DNA damage. H1.4 interacts with core histones (H2A, H2B, H3, H4), HP1, PARP1, and SWI/SNF remodeling complexes, modulating chromatin accessibility and facilitating recruitment of chromatin modifiers to impact DNA replication, repair, and cellular senescence pathways.
In HEK293T cells, H1-4 knockout is expected to reduce chromatin compaction, leading to global increases in chromatin accessibility and derepression of H1.4-silenced genes. This decondensation can perturb transcriptional programs, cell cycle regulation, and stress responses, potentially revealing cryptic regulatory elements. The polyclonal cell population preserves editing heterogeneity, enabling robust analysis of dose-dependent effects and cellular variability. This model is particularly valuable for dissecting the functional interplay between linker histones and core histone modifications and for studying how chromatin decondensation influences DNA damage signaling and repair pathways.
Applications include chromatin accessibility profiling with ATAC-seq, histone modification mapping by ChIP-seq, transcriptome analysis via RNA-seq, and protein detection by Western blotting. Further assays such as immunofluorescence for chromatin structure, comet assays for DNA damage, and flow cytometry for cell cycle analysis are supported. These cells are also suitable for live-cell imaging of chromatin dynamics and high-content screening of epigenetic compounds. This model is a valuable resource for epigenetic drug screening and investigating chromatin-related diseases like cancer and neurodevelopmental disorders. For more information, contact Ascent Research.
